Journal of International Oncology››2015,Vol. 42››Issue (6): 422-425.doi:10.3760/cma.j.issn.1673-422X.2015.06.006
Previous ArticlesNext Articles
Ouyang Jie, Li Hong, Chen Siyuan, Wang Libin, Li Aihui, Liu Ming, Yu Weixuan
Received:
2014-12-21Online:
2015-06-08Published:
2015-05-31Contact:
Ouyang Jie E-mail:kitty865@163.comOuyang Jie, Li Hong, Chen Siyuan, Wang Libin, Li Aihui, Liu Ming, Yu Weixuan. Application of two different gastrectomy methods in proximal gastric cancer[J]. Journal of International Oncology, 2015, 42(6): 422-425.
[1] Ichikawa D, Komatsu S, Kubota T, et al. Longterm outcomes of patients who underwent limited proximal gastrectomy[J]. Gastric Cancer, 2014, 17(1): 141-145. [2] Ikeguchi M, Kader A, Takaya S, et al. Prognosis of patients with gastric cancer who underwent proximal gastrectomy[J]. Int Surg, 2012, 97(3): 275-279. [3] Nozaki I, Hato S, Kobatake T, et al. Longterm outcome after proximal gastrectomy with jejunal interposition for gastric cancer compared with total gastrectomy[J]. World J Surg, 2013, 37(3): 558-564. [4] Wen L, Chen XZ, Wu B, et al. Total vs. proximal gastrectomy for proximal gastric cancer: a systematic review and metaanalysis[J]. Hepatogastroenterology, 2012, 59(114): 633-640. [5] Nomura E, Lee SW, Kawai M, et al. Functional outcomes by reconstruction technique following laparoscopic proximal gastrectomy for gastric cancer: double tract versus jejunal interposition[J]. World J Surg Oncol, 2014, 12: 20. [6] Takiguchi N, Takahashi M, Ikeda M, et al. Longterm qualityoflife comparison of total gastrectomy and proximal gastrectomy by postgastrectomy syndrome assessment scale (PGSAS45): a nationwide multiinstitutional study[J]. Gastric Cancer, 2014, In press. [7] Wu H, He YL, Xu JB, et al. Impact of different gastrectomy and reconstruction methods on prognosis and quality of life in proximal gastric cancer[J]. Zhonghua Wai Ke Za Zhi, 2012, 50(10): 875-878. [8] Namikawa T, Oki T, Kitagawa H, et al. Impact of jejunal pouch interposition reconstruction after proximal gastrectomy for early gastric cancer on quality of life: short and longterm consequences[J]. Am J Surg, 2012, 204(2): 203-209. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Fan Zhipeng, Yu Jing, Hu Jing, Liao Zhengkai, Xu Yu, Ouyang Wen, Xie Conghua.Predictive value of changes in inflammatory markers for prognosis in patients with advanced non-small cell lung cancer treated with the first-line immunotherapy plus chemotherapy[J]. Journal of International Oncology, 2024, 51(5): 257-266. |
[5] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[6] | Liu Pingping, He Xuefang, Zhang Yi, Yang Xu, Zhang Shanshan, Ji Yifei.Risk factors of postoperative recurrence in patients with primary brain glioma and prediction model construction[J]. Journal of International Oncology, 2024, 51(4): 193-197. |
[7] | Wan Fang, Yang Gang, Li Rui, Wan Qijing.Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer[J]. Journal of International Oncology, 2024, 51(4): 204-209. |
[8] | Yao Yixin, Shen Yulin.Predictive value of serum SOCS3 and TXNIP levels for the prognosis of patients with hepatocellular carcinoma treated with TACE[J]. Journal of International Oncology, 2024, 51(4): 217-222. |
[9] | Sun Weiwei, Yao Xuemin, Wang Pengjian, Wang Jing, Jia Jinghao.Exploration of prognostic factors and nomogram construction for advanced non-small cell lung cancer treated with immunotherapy based on hematologic indexes[J]. Journal of International Oncology, 2024, 51(3): 143-150. |
[10] | Xie Shuping, Sun Yahong, Wang Chao.Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 157-165. |
[11] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180. |
[12] | Peng Qin, Cai Yuting, Wang Wei.Advances on KPNA2 in liver cancer[J]. Journal of International Oncology, 2024, 51(3): 181-185. |
[13] | Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[14] | Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104. |
[15] | Huang Zhen, Chen Yongshun.Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma[J]. Journal of International Oncology, 2024, 51(1): 59-64. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||